SCHEMBL6983946

SCHEMBL6983946

Cc1ccc(S(=O)(=O)OC[C@H]2COc3ccc(F)c(F)c3O2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.39
ALDH1A1 P00352 2/20 0.38
CYP3A4 P08684 2/20 0.38
CYP2D6 P10635 2/20 0.38
TSHR P16473 2/20 0.38
MAPK1 P28482 2/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
MAPT P10636 1/20 0.38
CA2 P00918 3/20 0.37
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
HSP90AA1 P07900 1/20 0.35
HSP90AB1 P08238 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.34
NPSR1 Q6W5P4 1/20 0.33
PTGS2 P35354 2/20 0.33
HTR6 P50406 1/20 0.33
PRMT5 O14744 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1873064 1.00 LMNA (0.41) LMNASMN1; SMN2ALDH1A1CYP3A4CYP2D6
SCHEMBL5844958 0.87 LMNA (0.46) LMNASMN1; SMN2ALDH1A1CYP3A4CYP2D6
SCHEMBL1021389 0.87 LMNA (0.46) LMNASMN1; SMN2ALDH1A1CYP3A4CYP2D6
SCHEMBL7679738 0.86 LMNA (0.42) LMNASMN1; SMN2ALDH1A1CYP3A4CYP2D6
SCHEMBL6105413 0.85 LMNA (0.41) LMNASMN1; SMN2ALDH1A1CYP3A4CYP2D6
SCHEMBL4961837 0.85 LMNA (0.41) LMNASMN1; SMN2ALDH1A1CYP3A4CYP2D6
SCHEMBL7676015 0.84 LMNA (0.42) LMNASMN1; SMN2ALDH1A1CYP3A4CYP2D6
SCHEMBL4961140 0.83 LMNA (0.39) LMNASMN1; SMN2ALDH1A1CYP3A4CYP2D6
Hydrochloric Acid SCHEMBL6764944 0.83 LMNA (0.41) LMNASMN1; SMN2ALDH1A1CYP3A4CYP2D6
SCHEMBL1042355 0.82 LMNA (0.46) LMNASMN1; SMN2ALDH1A1CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0839145-B1 HETEROCYCLYLCARBOXAMIDE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS ABBOTT GMBH & CO KG (DE) 2003-11-05 EP disclosed
US-5935973-A AFFINITY FOR 5-HT1A, ALPHA1, ALPHA2 AND/OR D2 RECEPTORS; ANTIDEPRESSANTS, ANXIOLYTIC AGENTS, PSYCHOSES, DYSKINESIAS, PARKINSON'S DISEASE, HYPOTENSIVE AGENTS, TOURETTE'S SYNDROME, OBSESSIVE-COMPULSIVE BEHAVIOUR, PANIC ATTACKS, SOCIAL PHOBIAS KNOLL AKTIENGESELLSCHAFT (DE) 1999-08-10 US disclosed
EP-0839145-A1 HETEROCYCLYLCARBOXAMIDE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS Knoll AG (DE) 1998-05-06 EP disclosed
WO-1997003071-A1 HETEROCYCLYLCARBOXAMIDE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS KNOLL AKTIENGESELLSCHAFT (DE) 1997-01-30 WO disclosed